{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/02/3305287/0/en/Cardiff-Oncology-Announces-Presentation-of-Positive-Results-from-its-Randomized-Controlled-Phase-2-Trial-of-Onvansertib-in-First-Line-RAS-Mutated-mCRC-at-the-2026-ASCO-Annual-Meeti.html", "message": "News view counter 773472 successfully enlarged"}